Research programme: A H5N1 influenza vaccine - FluGen
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator FluGen
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype in USA
- 31 Dec 2009 Preclinical trials in Influenza-A virus H5N1 subtype in USA (unspecified route)
- 25 Mar 2009 Early research in Influenza virus infections in USA (Intradermal)